Hiroshi Miyanaka
- Molecular Biology
- Immunology top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Physiology
- Pulmonary and Respiratory Medicine
- Co-authors
- Nozomu NishiTakanori NakamuraHiroki ShojiAiko ItohToshitaka NakagawaMasaki UenoFumio WadaKunio Matsumoto
- Topics
- Peptidase Inhibition and Analysis (4 papers)Galectins and Cancer Biology (4 papers)Hormonal and reproductive studies (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- Japan
In The Last Decade
Hiroshi Miyanaka
21 papers receiving 756 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 343
- Immunology 221
- Endocrinology, Diabetes and Metabolism 118
- Physiology 92
- Pulmonary and Respiratory Medicine 82
Countries citing papers authored by Hiroshi Miyanaka
This map shows the geographic impact of Hiroshi Miyanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Miyanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Miyanaka more than expected).
Fields of papers citing papers by Hiroshi Miyanaka
This network shows the impact of papers produced by Hiroshi Miyanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Miyanaka. The network helps show where Hiroshi Miyanaka may publish in the future.
Co-authorship network of co-authors of Hiroshi Miyanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Miyanaka. A scholar is included among the top collaborators of Hiroshi Miyanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Miyanaka. Hiroshi Miyanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 54 | |
| 7 | 55 | |
| 8 | 71 | |
| 9 | 140 | |
| 10 | 23 | |
| 11 | 15 | |
| 12 | 92 | |
| 13 | 4 | |
| 14 | 36 | |
| 15 | 94 | |
| 16 | 16 | |
| 17 | 11 | |
| 18 | 8 | |
| 19 | 23 | |
| 20 | 7 |
About Hiroshi Miyanaka
Hiroshi Miyanaka is a scholar working on Cell Biology, Endocrine and Autonomic Systems and Neurology, having authored 21 papers that have together received 769 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Galectins and Cancer Biology (4 papers) and Hormonal and reproductive studies (3 papers). The work is most often cited by research in Immunology (221 citations), Neurology (81 citations) and Endocrinology, Diabetes and Metabolism (118 citations). Hiroshi Miyanaka has collaborated with scholars based in Japan. Frequent co-authors include Nozomu Nishi, Takanori Nakamura, Hiroki Shoji, Aiko Itoh, Toshitaka Nakagawa, Masaki Ueno, Fumio Wada, Kunio Matsumoto, Masako Seki and Toshikazu Nakamura. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.